Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-02-03 @ 7:08 AM
Study NCT ID:
NCT02129556
Status:
COMPLETED
Last Update Posted:
2019-02-15
First Post:
2014-04-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer
Sponsor:
ETOP IBCSG Partners Foundation
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
IBCSG 45-13 / BIG 4-13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |